Surgical site infection in hepatobiliary surgery patients and its relationship with serum vitamin D concentration.

Infección del sitio quirúrgico en cirugía hepatobiliopancreática y su relación con la concentración sérica de vitamina D.

Journal

Cirugia espanola
ISSN: 2173-5077
Titre abrégé: Cir Esp (Engl Ed)
Pays: Spain
ID NLM: 101771152

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 31 10 2019
revised: 03 03 2020
accepted: 09 03 2020
pubmed: 30 7 2020
medline: 20 7 2021
entrez: 30 7 2020
Statut: ppublish

Résumé

While several studies have examined the correlation between vitamin D concentrations and post-surgical nosocomial infections, this relationship has yet to be characterized in hepatobiliary surgery patients. We investigated the relationship between serum vitamin D concentration and the incidence of surgical site infection (SSI) in patients in our hepatobiliary surgery unit. Participants in this observational study were 321 successive patients who underwent the following types of interventions in the hepatobiliary surgery unit of our center over a 1-year period: cholecystectomy, pancreaticoduodenectomy, total pancreatectomy, segmentectomy, hepatectomy, hepaticojejunostomy and exploratory laparotomy. Serum vitamin D levels were measured upon admission and patients were followed up for 1 month. Mean group values were compared using a Student's T-test or Chi-squared test. Statistical analyses were performed using the Student's T-test, the Chi-squared test, or logistic regression models. Serum concentrations >33.5 nmol/l reduced the risk of SSI by 50%. Out of the 321 patients analyzed, 25.8% developed SSI, mainly due to organ-cavity infections (incidence, 24.3%). Serum concentrations of over 33.5 nmol/l reduced the risk of SSI by 50%. High serum levels of vitamin D are a protective factor against SSI (OR, 0.99). Our results suggest a direct relationship between serum vitamin D concentrations and SSI, underscoring the need for prospective studies to assess the potential benefits of vitamin D in SSI prevention.

Identifiants

pubmed: 32723503
pii: S0009-739X(20)30072-5
doi: 10.1016/j.ciresp.2020.03.004
pii:
doi:

Substances chimiques

Vitamin D 1406-16-2

Types de publication

Comparative Study Journal Article Observational Study

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

456-464

Informations de copyright

Copyright © 2020 AEC. Publicado por Elsevier España, S.L.U. All rights reserved.

Auteurs

Estefania Laviano (E)

Servicio de Cirugía General y Digestiva, Hospital Miguel Servet, Zaragoza, España. Electronic address: estefania.laviano@gmail.com.

María Sanchez (M)

Servicio de Cirugía General y Digestiva, Hospital Miguel Servet, Zaragoza, España.

María Teresa González-Nicolás (MT)

Servicio de Cirugía General y Digestiva, Hospital Miguel Servet, Zaragoza, España.

María Pilar Palacian (MP)

Servicio de Microbiología, Hospital Miguel Servet, Zaragoza, España.

Javier López (J)

Medicina Familiar y Comunitaria, Sector II, Zaragoza, España.

Yolanda Gilaberte (Y)

Servicio de Dermatología, Hospital Miguel Servet, Zaragoza, España.

Pilar Calmarza (P)

Servicio de Bioquímica, Hospital Miguel Servet, Zaragoza, España.

Antonio Rezusta (A)

Servicio de Microbiología, Hospital Miguel Servet, Zaragoza, España.

Alejandro Serrablo (A)

Servicio de Cirugía General y Digestiva, Hospital Miguel Servet, Zaragoza, España.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH